Skip to Main Content

Author Details

Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
2006
53
24
PMIDPaper TitleJournal TitlePublished Year
36601953Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.Cancer Sci2023
37459099First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.JAMA Netw Open2023
36690964Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer.BMC Cancer2023
36832239A Primary Kidney Giant Cell Tumor of Soft Tissue Caused Peritoneal Dissemination, Considered to Be Malignant Transformation: A Case Report.Diagnostics (Basel)2023
34896892MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.Oral Oncol2022
35593736First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.Cancer2022
35358259Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study.PLoS One2022
35851351[Ovarian Carcinosarcoma Associated with Cowden Syndrome-A Case Report].Gan To Kagaku Ryoho2022
36455506Targeting the FGF/FGFR axis and its co-alteration allies.ESMO Open2022
36108261Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies.JCO Precis Oncol2022
36360466Fighting Cancer around the World: A Framework for Action.Healthcare (Basel)2022
36351642[Malignant paraganglioma mimicking multiple myeloma].Rinsho Ketsueki2022
35884537Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer.Cancers (Basel)2022
36324736Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high <i>ACE2</i>-expressing normal lung.Ther Adv Med Oncol2022
34904768Primary pulmonary choriocarcinoma with a genomic sequence.Pathol Int2022
33249514Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).Int J Clin Oncol2021
33792431Basaloid Squamous Cell Carcinoma of the Uterine Cervix: Report of a Case With Molecular Analysis.Int J Surg Pathol2021
33710417Estimating copy number using next-generation sequencing to determine ERBB2 amplification status.Med Oncol2021
33782800ASO Author Reflections: Impact of Liquid Biopsy Using Plasma Cell-Free DNA in Solid Tumors in Japan.Ann Surg Oncol2021
33778906A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study).Ann Surg Oncol2021
33528846KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery.Oncologist2021
34378333Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases.Thorac Cancer2021
34677235Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal <i>MET</i> Amplification from Aneuploidy in Diverse Advanced Cancers.Curr Oncol2021
32117584Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity.Oncoimmunology2020
32769873A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial).Medicine (Baltimore)2020
32956529Multiplex gene-panel testing for lung cancer patients.Pathol Int2020
32363992Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.Immunotherapy2020
30339521Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing.Cancer Biol Ther2019
31748480[Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)].Gan To Kagaku Ryoho2019
31363003Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.Clin Cancer Res2019
29038235Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach.Oncologist2018
29866143MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis.J Hematol Oncol2018
29487225Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.Oncologist2018
29483209Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics.Mol Cancer Ther2018
29133621The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA.Mol Cancer Ther2018
28788102Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease.Int J Mol Sci2017
28241173JAK1 Genomic Alteration Associated With Exceptional Response to Siltuximab in Cutaneous Castleman Disease.JAMA Dermatol2017
28854942The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.Mol Cancer2017
28807936Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing.Cancer Res2017
27496136Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.Mol Cancer Ther2016
27942391Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy.NPJ Genom Med2016
27388585Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19⿯784 Diverse Solid Tumors.JAMA Oncol2016
26138514Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.Cancer Treat Rev2015
26210103Molecular landscape of prostate cancer: implications for current clinical trials.Cancer Treat Rev2015
22228770Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.J Biol Chem2012
22733742Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.Proc Natl Acad Sci U S A2012
20415651Expression and function of microRNAs in heart disease.Curr Drug Targets2010
20651241Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.Am J Pathol2010
20124440Heart failure-associated changes in RNA splicing of sarcomere genes.Circ Cardiovasc Genet2010
19188439MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes.Mol Cell Biol2009
  • 1 - 50 of 53

Recommended Authors

Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 0
Yang Shao
Nanjing Geneseeq Technology Inc.
Career Start Year 2012
Number of shared co-authors 0
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 0
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 2
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 0
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 1
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 1
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 2
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 0
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 2
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2002
Number of shared co-authors 0
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 0
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 0
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 2
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 4
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 3
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Siraj M Ali
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 6
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 2
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 1
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 7
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 6

Collaborators

William T Pu
Boston Children's Hospital, Harvard Medical School
Co-authored papers 8
Egbert Bisping
Medical University of Graz
Co-authored papers 4
Sek Won Kong
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 4
Qing Ma
Boston Children's Hospital
Co-authored papers 3
AmirAli Talasaz
University of California San Diego Moores Cancer Center
Co-authored papers 3
Burkert Pieske
Charite University Medicine, Berlin Institute of Health (BIH)
Co-authored papers 3
Natalya Bodyak
Beth Israel Deaconess Medical Center
Co-authored papers 2
Benjamin Solomon
Peter MacCallum Cancer Centre
Co-authored papers 2
Seigo Izumo
Beth Israel Deaconess Medical Center.
Co-authored papers 2
Paul T Fanta
University of California San Diego Moores Cancer Center
Co-authored papers 2
Conjeevaram S Pramesh
Homi Bhabha National Institute
Co-authored papers 2
Peter M Kang
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 2
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 2
Julie R McMullen
Baker Heart and Diabetes Institute
Co-authored papers 2
Oleg Tarnavski
Novartis Institutes for BioMedical Research, Inc. Cambridge
Co-authored papers 2
Satish K Rajagopal
Benioff Children's Hospital, University of California san francisco
Co-authored papers 2
Jun Lu
Yale University
Co-authored papers 2
Zhiyuan Zhang
Co-authored papers 1
Hiroyuki Mano
Co-authored papers 1
Donald L Durden
Atrium Health-Levine Cancer Institute
Co-authored papers 1
Paul D Allen
Leeds Institute of Medical Research, University of Leeds
Co-authored papers 1
Alok R Singh
university of california san diego Department of Pediatrics, University of California
Co-authored papers 1
Hao Zhang
Co-authored papers 1
David Zurakowski
Harvard Medical School, Boston Children's Hospital
Co-authored papers 1
Jennifer L Hall
Institute for Precision Cardiovascular Medicine
Co-authored papers 1
Joel M Baumgartner
University of California
Co-authored papers 1
Jos?? Rivera-Feliciano
Harvard University
Co-authored papers 1
Jennifer K Son
Department of Radiology- Johns Hopkins University School of Medicine
Co-authored papers 1
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Co-authored papers 1
Alexander von Gise
Hannover Medical School
Co-authored papers 1
Release 1.2